Ensol Biosciences (XKRX:140610) EV-to-EBITDA : -7.08 (As of Jun. 23, 2024)

Ensol Biosciences EV-to-EBITDA Chart

Ensol Biosciences Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA		Get a 7-Day Free Trial					-15.34	-13.15	-15.88	-21.20	-7.44

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial					-15.34	-13.15	-15.88	-21.20	-7.44

Competitive Comparison of Ensol Biosciences's EV-to-EBITDA

For the Biotechnology subindustry, Ensol Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ensol Biosciences's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ensol Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ensol Biosciences's EV-to-EBITDA falls into.

Ensol Biosciences EV-to-EBITDA Calculation

Ensol Biosciences's EV-to-EBITDA for today is calculated as:

Ensol Biosciences's current Enterprise Value is ₩67,946.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ensol Biosciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-9,592.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ensol Biosciences  (XKRX:140610) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ensol Biosciences's PE Ratio for today is calculated as:

Ensol Biosciences's share price for today is ₩5900.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ensol Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1054.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Ensol Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences (XKRX:140610) Business Description